摘要
背景:缺血心脏过度释放去甲肾上腺素(NE)可引起严重且常致命性心律失常。常驻心脏肥大细胞合成和储存活性肾素,在脱颗粒时释放,导致局部心脏肾素-血管紧张素系统(RAS)激活,负责NE释放和随后的心律失常。已知由缺血/再灌注(I/R)的脂质过氧化(I/R)形成的有毒醛类物质可以使肥大细胞脱颗粒,并激活局部RAS。目的:探讨缺血预适应(IPC)及其受体在抗RAS心肌保护中的作用.方法:在离体条件下建立离体心肌、小鼠心脏I/R模型,体外培养人和小鼠肥大细胞株。结果:IPC不仅能显著减轻缺血后的损伤,而且能降低肥大细胞肾素的释放,从而起到抗RAS的心脏保护作用。同样,在肥大细胞表面表达的组胺-H4、腺苷-A3和鞘氨醇-1-磷酸-S1P1受体等Gicouded受体的激活,类似于IPC的抗心肌保护作用。这种作用的机制取决于蛋白激酶C、pkcε和线粒体醛脱氢酶2(ALDH 2)的特异性亚型的连续激活。ALDH 2酶活性的提高在抑制醛诱导的肥大细胞肾素释放、抑制RAS活化、减少NE释放和减轻再灌注心律失常中起着重要作用。结论:这些新发现的保护途径表明,肥大细胞Gicouded受体的激活和随后的ALDH 2磷酸化/激活是缓解RAS所致心脏功能障碍(包括缺血性心脏病和充血性心力衰竭)的一个新的治疗靶点。
关键词: 乙醛脱氢酶2型,GI偶联蛋白,缺血再灌注,缺血预处理,肥大细胞,去甲肾上腺素。
Current Medicinal Chemistry
Title:Salvaging the Ischemic Heart: Gi-Coupled Receptors in Mast Cells Activate a PKCε/ALDH2 Pathway Providing Anti-RAS Cardioprotection
Volume: 25 Issue: 34
关键词: 乙醛脱氢酶2型,GI偶联蛋白,缺血再灌注,缺血预处理,肥大细胞,去甲肾上腺素。
摘要: Background: Excessive norepinephrine (NE) release in the ischemic heart elicits severe and often lethal arrhythmias. Resident cardiac mast cells synthesize and store active renin, which is released upon degranulation, causing the activation of a local cardiac renin-angiotensin system (RAS) responsible for NE release and consequent arrhythmias. Toxic aldehydes, known to be formed by lipid peroxidation in ischemia/reperfusion (I/R), have been shown to degranulate mast cells and activate a local RAS.
Objective: To provide an up-to-date description of the roles of ischemic preconditioning (IPC) and Gicoupled receptors in anti-RAS cardioprotection.
Methods: Ex-vivo I/R models in cavian and murine hearts, and human and murine mast cell lines in vitro.
Results: IPC not only drastically reduces the injury subsequent to a prolonged ischemic event, but also decreases mast cell renin release, thus affording anti-RAS cardioprotection. Similarly, activation of Gicoupled receptors, such as histamine-H4, adenosine-A3 and sphingosine-1-phosphate-S1P1 receptors, all expressed at the mast cell surface, mimic the cardioprotective anti-RAS effects of IPC. The mechanism of this action depends on the sequential activation of a specific isoform of protein kinase C, PKCε, and mitochondrial aldehyde dehydrogenase-type 2 (ALDH2). Increased ALDH2 enzymatic activity exerts a pivotal role in the sequential inhibition of aldehyde-induced mast-cell renin release, prevention of RAS activation, reduction of NE release and alleviation of reperfusion arrhythmias.
Conclusion: These recently discovered protective pathways indicate that activation of mast-cell Gicoupled receptors and subsequent ALDH2 phosphorylation/activation represent a novel therapeutic target for the alleviation of RAS-induced cardiac dysfunctions, including ischemic heart disease and congestive heart failure.
Export Options
About this article
Cite this article as:
Salvaging the Ischemic Heart: Gi-Coupled Receptors in Mast Cells Activate a PKCε/ALDH2 Pathway Providing Anti-RAS Cardioprotection, Current Medicinal Chemistry 2018; 25 (34) . https://dx.doi.org/10.2174/0929867325666180214115127
DOI https://dx.doi.org/10.2174/0929867325666180214115127 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Intracellular 35-Cyclic Adenosine Monophosphate (cAMP) in Atherosclerosis
Current Vascular Pharmacology Clinical Management of the Cardiovascular Failure in Sepsis
Current Vascular Pharmacology Current Pharmacological Approach to Restore Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry Integrative Neurochemistry and Neurobiology of Social Recognition and Behavior Analyzed with Respect to CD38-Dependent Brain Oxytocin Secretion
Current Topics in Medicinal Chemistry Role of Heme Oxygenases in Cardiovascular Syndromes and Co-morbidities
Current Pharmaceutical Design Strategies for Integral Metabolism Profile of Multiple Compounds in Herbal Medicines: Pharmacokinetics, Metabolites Characterization and Metabolic Interactions
Current Drug Metabolism Natural Antioxidants in Wheat Sprout Extracts
Current Organic Chemistry Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
Current Cardiology Reviews Bioavailability of Quercetin: Problems and Promises
Current Medicinal Chemistry Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Use of Antioxidants in Sepsis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Current Medicinal Chemistry PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Current Pharmaceutical Design Physiologic Responses in Anxiety
Current Psychiatry Reviews Recent Advances in Nanoparticle Carriers for Coordination Complexes
Current Topics in Medicinal Chemistry Xanthine Oxidase Inhibitors the Unappreciated Treatment for Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Is Type D Personality Here to Stay? Emerging Evidence Across Cardiovascular Disease Patient Groups
Current Cardiology Reviews